isSCC
Sirnaomics advances isSCC candidate into late-stage clinical development
June 20, 2023Research and Development FDA, Oncology, Sirnaomics, clinical trial, isSCC
Global RNA therapeutics biopharmaceutical company Sirnaomics has announced that it has advanced its Squamous Cell Carcinoma in situ (isSCC) candidate …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
